Cargando…
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer
Prostate-specific membrane antigen (PSMA) is an important cell surface target in prostate cancer. There are limited data on the heterogeneity of PSMA tissue expression in metastatic castration-resistant prostate cancer (mCRPC). Furthermore, the mechanisms regulating PSMA expression (encoded by the F...
Autores principales: | Sayar, Erolcan, Patel, Radhika A., Coleman, Ilsa M., Roudier, Martine P., Zhang, Ailin, Mustafi, Pallabi, Low, Jin-Yih, Hanratty, Brian, Ang, Lisa S., Bhatia, Vipul, Adil, Mohamed, Bakbak, Hasim, Quigley, David A., Schweizer, Michael T., Hawley, Jessica E., Kollath, Lori, True, Lawrence D., Feng, Felix Y., Bander, Neil H., Corey, Eva, Lee, John K., Morrissey, Colm, Gulati, Roman, Nelson, Peter S., Haffner, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132157/ https://www.ncbi.nlm.nih.gov/pubmed/36821396 http://dx.doi.org/10.1172/jci.insight.162907 |
Ejemplares similares
-
Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
por: Coleman, Ilsa M., et al.
Publicado: (2022) -
Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations
por: Patel, Radhika A., et al.
Publicado: (2022) -
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
por: Bhatia, Vipul, et al.
Publicado: (2023) -
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
por: Brady, Lauren, et al.
Publicado: (2021) -
Mismatch repair enzyme expression in primary and castrate resistant prostate cancer
por: Nghiem, Belinda, et al.
Publicado: (2016)